
KMC Speciality Hospitals Q1 FY27: PAT surges 120% YoY as margins expand, revenue +38%
KMC Speciality Hospitals (Kauvery Hospital, Trichy) reported standalone Q1 FY27 revenue from operations of ₹91.78 Cr, up 37.9% YoY from ₹66.55 Cr and up 11.6% QoQ from ₹82.25 Cr. Standalone PAT more than doubled YoY to ₹16.57 Cr from ₹7.54 Cr (+119.9%), and rose 13.3% QoQ from ₹14.63 Cr, with EPS at ₹1.02 versus ₹0.46 a year ago and ₹0.90 last quarter. There are no exceptional or one-off items disclosed in either period, so the YoY jump is organic rather than a base-effect artefact. The profit growth was driven by operating leverage: total expenses rose 24.1% YoY (₹71.15 Cr vs ₹57.35 Cr) while total income rose 39.0% YoY, so operating profit margin (EBITDA/revenue) expanded to 31.0% from 24.7% a year ago, and net profit margin expanded to 17.7% from 11.2%. Employee benefits expense (+27.6% YoY) and other expenses (+28.0% YoY) grew broadly in line with volumes, but finance costs actually declined YoY (₹2.00 Cr vs ₹2.16 Cr) despite the larger revenue base, adding directly to the bottom line. Sequentially margins were roughly flat-to-softer (OPM 31.0% now vs 31.5% in Q4 FY26), so the YoY expansion is the more meaningful signal per our comparison hierarchy. There is no formal management guidance on record from our database or the filing, and no analyst/brokerage consensus or Q1 preview could be found for this stock in web search — as a small, single-facility standalone hospital company it does not appear to carry formal sell-side coverage, so both vs-guidance and vs-street are unknown rather than beat/miss. The filing itself carries no MD&A or press-release commentary beyond the standard boilerplate notes (single-segment disclosure, review report details), so there is no management framing to reconcile against the numbers this quarter. Separately, the company disclosed promoter share encumbrances on August 5 and August 12, 2026, just ahead of this result — a shareholding-pattern item unrelated to the operating print but worth flagging as it surfaced in the same week.
Key Highlights
- Revenue from operations ₹91.78 Cr, +37.9% YoY (₹66.55 Cr) and +11.6% QoQ (₹82.25 Cr)
- PAT ₹16.57 Cr, +119.9% YoY (₹7.54 Cr) and +13.3% QoQ (₹14.63 Cr) — no exceptional items either period
- NPM expanded to 17.7% from 11.2% YoY; OPM to 31.0% from 24.7% YoY (vs 31.5% last quarter, roughly flat sequentially)
- EPS ₹1.02 (not annualised) vs ₹0.46 in Q1 FY26 and ₹0.90 in Q4 FY26
- Total expenses grew 24.1% YoY (₹71.15 Cr) versus 39.0% total income growth, driving the margin expansion
- Finance costs fell YoY to ₹2.00 Cr from ₹2.16 Cr despite the larger revenue base
- Promoter share encumbrance disclosed Aug 5 and Aug 12, 2026 — unrelated to the operating result
Price Impact
More from KMCSHIL